Successful treatment of nevoid psoriasis with Secukinumab in a pediatric patient

Dermatol Ther. 2022 Jun;35(6):e15456. doi: 10.1111/dth.15456. Epub 2022 Mar 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized*
  • Child
  • Double-Blind Method
  • Humans
  • Psoriasis* / diagnosis
  • Psoriasis* / drug therapy
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • secukinumab